Release Date: 29/07/09 11:24 Summary: Fourth Quarter Activities and Cashflow Reports Price Sensitive: Yes Download Document 170.51KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling